OrbiMed’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.31M | Buy |
+531,163
| New | +$5.31M | 0.13% | 74 |
|
|
2024
Q2 | – | Sell |
-16,154
| Closed | -$16.7M | – | 110 |
|
|
2024
Q1 | $16.7M | Sell |
16,154
-5,473
| -25% | -$5.66M | 0.31% | 71 |
|
|
2023
Q4 | $17.1M | Hold |
21,627
| – | – | 0.34% | 65 |
|
|
2023
Q3 | $10.3M | Hold |
21,627
| – | – | 0.22% | 81 |
|
|
2023
Q2 | $13M | Hold |
21,627
| – | – | 0.24% | 79 |
|
|
2023
Q1 | $15.3M | Sell |
21,627
-74
| -0.3% | -$52.2K | 0.3% | 75 |
|
|
2022
Q4 | $22.3M | Sell |
21,701
-1,013
| -4% | -$1.04M | 0.43% | 64 |
|
|
2022
Q3 | $13.2K | Buy |
22,714
+9,040
| +66% | +$5.25K | 0.24% | 78 |
|
|
2022
Q2 | $7.48K | Sell |
13,674
-896
| -6% | -$490 | 0.14% | 100 |
|
|
2022
Q1 | $9.35M | Sell |
14,570
-736
| -5% | -$472K | 0.15% | 102 |
|
|
2021
Q4 | $6.32M | Hold |
15,306
| – | – | 0.08% | 128 |
|
|
2021
Q3 | $11.2M | Hold |
15,306
| – | – | 0.12% | 120 |
|
|
2021
Q2 | $12.2M | Buy |
+15,306
| New | +$12.2M | 0.12% | 118 |
|